// App-Quantinova.ai

2115220 : RISK FACTORS FOR VERY LATE STENT THROMBOSIS AFTER SIROLIMUSELUTING STENT IMPLANTATION AND IMPACT OF DISCONTINUATION OF THIENOPYRIDINE THERAPY

Researchers

Presenter

  • Yasushi Fuku

Principal Investigators

  • Kazushige Kadota

  • Yusuke Hyodo

  • Takeshi Tada

  • Koshi Miyake

  • Yuki Hayakawa

  • Naoki Saito

  • Hideaki Otsuji

  • Suguru Otsuru

  • Daiji Hasegawa

  • Yoshikazu Shigemoto

  • Seiji Habara

Medical Centers

  • Kurashiki Central Hospital, Kurashiki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved